Tower Research Capital (TRC)’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Tower Research Capital (TRC)’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-188	Closed	–	–	5418
2014 Q4	$0	Sell	188 -4,357	-96%	-$2.63K	﹤0.01%	5321
2014 Q3	$3K	Sell	4,545 -128	-3%	-$162	﹤0.01%	3713
2014 Q2	$6K	Buy	4,673 +695	+17%	+$996	﹤0.01%	2793
2014 Q1	$8K	Buy	3,978 +2,378	+149%	+$4.01K	﹤0.01%	2906
2013 Q4	$3K	Sell	1,600 -244	-13%	-$550	﹤0.01%	3931
2013 Q3	$5K	Buy	1,844 +968	+111%	+$2.68K	﹤0.01%	3727
2013 Q2	$3K	Buy	+876	New	+$2.42K	﹤0.01%	3392

Other funds holding ONCY

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

VFS

VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return

NCCM

Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return

Scotia Capital Toronto, Ontario, Canada $26.8B AUM 33.07% 1-Year Est. Return

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Tower Research Capital (TRC)'s ONCY Position: Q1 2015 in Review

Tower Research Capital (TRC) sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q1 2015, closing a stake of 188 shares.

Tower Research Capital (TRC) first reported a position in ONCY in Q2 2013 and held it in 7 quarters. The position peaked at $8K in Q1 2014. 29 funds tracked by Wall St. Rank hold ONCY as of Q1 2015.

Tower Research Capital (TRC) reported no remaining ONCOLYTICS BIOTECH INC position as of Q1 2015 after selling out during the quarter.
Tower Research Capital (TRC) sold 188 ONCOLYTICS BIOTECH INC shares in Q1 2015.
Tower Research Capital (TRC) first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 7 quarters.
Tower Research Capital (TRC)'s ONCOLYTICS BIOTECH INC position peaked at $8K in Q1 2014.
29 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q1 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2015, filed 12 May 2015.